Novavax: COVID-19 Vaccine “89.3% Effective” In UK Trial
Novavax COVID-19 vaccine “89.3% effective” in UK clinical trial. Novavax Inc on Thursday said that its COVID-19 vaccine was 89.3% effective in preventing the coronavirus disease in a clinical trial conducted in the UK. According to a preliminary analysis, Novavax COVID-19 vaccine was “nearly as effective” in protecting against the more highly-contagious coronavirus variant first … Read more
